Vorinostat and fenretinide synergize in preclinical models of T-cell lymphoid malignancies-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Vorinostat and fenretinide synergize in preclinical models of T-cell lymphoid malignancies

Published:2020-10-19 Issue:1 Volume:32 Page:34-43
ISSN:0959-4973
Container-title:Anti-Cancer Drugs
language:en
Short-container-title:

Author:

Makena Monish Ram,Nguyen Thinh H.,Koneru Balakrishna,Hindle Ashly,Chen Wan-Hsi,Verlekar Dattesh U.,Kang Min H.,Reynolds C. Patrick

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology (medical),Pharmacology,Oncology

Reference52 articles.

1. Mechanisms of T cell development and transformation.;Koch;Annu Rev Cell Dev Biol,2011

2. International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes.;Vose;J Clin Oncol,2008

3. Management of cutaneous T cell lymphoma: new and emerging targets and treatment options.;Li;Cancer Manag Res,2012

4. Late recurrence of childhood T-cell acute lymphoblastic leukemia frequently represents a second leukemia rather than a relapse: first evidence for genetic predisposition.;Szczepanski;J Clin Oncol,2011

5. Adverse effects of treatment in childhood acute lymphoblastic leukemia: general overview and implications for long-term cardiac health.;Ness;Expert Rev Hematol,2011

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research on the mechanism of HOPX‐HDAC2 interaction inducing differentiation blockage in acute myeloid leukemia;Hematological Oncology;2024-09

2. TSA attenuates the progression of c-Myc-driven hepatocarcinogenesis by pAKT-ADH4 pathway;BMC Cancer;2024-08-26

3. The combination of brentuximab vedotin and chidamide synergistically suppresses the proliferation of T-cell lymphoma cells through the enhancement of apoptosis;Cancer Chemotherapy and Pharmacology;2023-11-03

4. Design, synthesis and biological evaluation of 2,4-pyrimidinediamine derivatives as ALK and HDACs dual inhibitors for the treatment of ALK addicted cancer;Journal of Enzyme Inhibition and Medicinal Chemistry;2022-09-13

5. Sphingolipids and Lymphomas: A Double-Edged Sword;Cancers;2022-04-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3